Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Chromatics Color Sciences International. Inc; CCSI -- Ignore unavailable to you. Want to Upgrade?

To: JanyBlueEyes who wrote (5671)	4/27/2000 12:42:00 PM
From: JanyBlueEyes	Respond to of 5736

Lawsuit History The lawsuit was brought about "on behalf of all purchasers of the common stock of the Company, between July 30, 1997 and June 9, 1998.....The complaint alleges that the Company "embarked upon a scheme" to inflate the price of the Company's Common Stock by making false and misleading statements concerning: (i) the new and innovative nature of the Company's ColorMate(Registered Trademark) TLc-BiliTest(Registered Trademark) System; (ii) the market size and revenue potential of the ColorMate(Registered Trademark) TLc-BiliTest(Registered Trademark) System; and (iii) the existence and status of negotiations with potential distributors of the ColorMate(Registered Trademark) TLc-BiliTest(Registered Trademark) System. The allegations of the complaint arise principally from a "report" prepared by Manuel I. Asensio of Asensio & Company, Inc. that was disseminated at the close of the putative class period...." "the court found that, regarding each of the company's statements at issue, "plaintiffs have either not sufficiently specified the reasons that the statements were misleading.....or failed to specify a reason that would be actionable under Section 10(b)." Addressing several of the allegations of false statements, the court said, "(E)ach of the allegedly false statements....is a factual statement whose truth is not in question. None of the statements were statements of optimism or even statements about promises regarding the future. They were factual statements about past events which included no promises as to the future and as such, plaintiffs have not adequately explained the basis on which the statements were false and misleading when made."

To: JanyBlueEyes who wrote (5671)	5/2/2000 8:56:00 AM
From: JanyBlueEyes	Read Replies (2) \| Respond to of 5736

NEWS - PREMIER HEALTHCARE ALLIANCE Premier Healthcare Alliance Adopts Chromatics' Pain-Free Infant Jaundice Monitor NEW YORK, May 2 /PRNewswire/ -- Chromatics Color Sciences International (Nasdaq: CCSI) announced today that Premier Purchasing Partners L.P., one of the nation's largest healthcare alliances, has added the ColorMate(R) TLc-BiliTest(R) non-invasive, pain-free infant jaundice monitoring system to its infant care products. The product is now included in the contract between Premier and CCSI's distributor in the United States, Datex-Ohmeda and its Ohmeda Medical Division, effective May 1, 2000. Premier is a strategic alliance of leading U.S. hospitals and healthcare systems representing 215 owners of 800 hospitals and healthcare facilities, along with 900 other affiliated hospitals across the U.S. Total annual purchasing volume for the alliance reached $12 billion in 1999. The decision to add the TLc-BiliTest(R) System came after it was reviewed by the Premier Technology Assessment Program. The Technology Assessment Report concluded, "When used properly, the system provides an effective aid to the physician in monitoring the status of newborn babies for the development of hyperbilirubinemia by displaying serum levels of bilirubin. The device can also be used for home or office measurement of those infants diagnosed with increasing clinical jaundice." CCSI Chief Executive Officer Darby Macfarlane said, "We are extremely pleased that Premier has agreed to enhance its infant care line with our product. This is a major step forward for our distributor to make the TLc-BiliTest(R) the standard of care for non-invasive, pain-free monitoring of infant jaundice all across the nation." Gregg Lauder, Director of Capital Equipment for Premier, said, "We see this as an exciting new addition for our members. Helping clinicians to reduce painful heelsticks in infants and manage infant jaundice at the same time will help our members provide a more positive birthing experience for both babies and their parents." Chromatics Color Sciences is in the business of color science.... Certain of the matters discussed in this announcement contain forward-looking statements....